Guides
#3DStartup: MB Therapeutics and its 3D Printed, Customizable Medication
In the field of personalized medicine, 3D printing is extending its scope beyond prostheses and implants to venture into an innovative field: medication. This technological advance opens up promising prospects for simplified treatments and personalized dosages tailored to patient
- 3 min read
- Guides
- Six more stories

In the field of personalized medicine, 3D printing is extending its scope beyond prostheses and implants to venture into an innovative field: medication. This technological advance opens up promising prospects for simplified treatments and personalized dosages tailored to patients’ unique profiles. Although this approach is still in its infancy, French startup MB-Therapeutics has taken the initiative to develop a solution.
Based at Montpellier’s Faculty of Pharmacy, MB-Therapeutics has unveiled its innovative process focused on the creation of personalized medicines using 3D printing. The fruit of eight years’ experience and research, the system, dubbed Med-U Modular, stands out for its patient-centric focus, initially dedicated to the needs of children. Founders Stéphane Roulon and Ian Soulairol aim to simplify the lives of young patients by exploiting the high degree of customization offered by 3D printing.
This technology enables MB-Therapeutics to design medicine with individually adapted dosages and shapes, combining several active ingredients within a single tablet. The ultimate goal is to overcome the constraints associated with taking multiple medications. We caught up with Stéphane Roulon, CEO and co-founder of MB Therapeutics, to find out more about these personalized medicines and the company’s future plans.





